284620.KS · 카이노스메드

South Korea · RS rating 67 · As of 2026-10-14

Price1,087.00 KRW
1-day change+0.0%
RS rating (overall / 1M / 3M / 12M)67 / 63 / 42 / 64
StageBasing
Composite / Minervini / CANSLIM score34 / 28 / 40
Industry group (rank)Medical-Biomed/Biotech (95)
EPS growth Q/Q+0.0%
Sales growth Q/Q+10.2%
Distance from 52-week high+0.0%
Market cap (USD)$26.5M
Open South Korea in the interactive screener